Wen-Feng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wen-Feng Zhang has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Zhi-Jun Sun
The State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430079, China
15 shared publications Liang Mao
12 shared publicationsLin-Lin Bu
10 shared publicationsWei-Wei Deng
10 shared publicationsGuang-Tao Yu
9 shared publicationsLei Wu
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei- MOST) and Key Laboratory of Oral Biomedicine, School and Hospital of Stomatology, Ministry of Education, Wuhan University, Wuhan, China
7 shared publications
Latest Publications
- RetractionOpen Access
- 6 January 2026
- Published by Impact Journals, LLC in Oncotarget
- Vol. 17 (1) , 202
Retraction: Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC
- 6 January 2026
- Published by Impact Journals, LLC in Oncotarget
- Vol. 17 (1) , 202
RetractionOpen AccessRetraction: Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC
- 1 January 2026
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 18 (5) , 4605-4610
AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma: Am J Transl Res. 2017; 9(2): 507-519
[This corrects the article on p. 507 in vol. 9, PMID: 28337279.].
- 1 January 2026
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 18 (5) , 4605-4610
AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma: Am J Transl Res. 2017; 9(2): 507-519
[This corrects the article on p. 507 in vol. 9, PMID: 28337279.].
- Open Access
- 21 October 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-8
Correction: Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
- 21 October 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-8
Open AccessCorrection: Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
- 1 January 2025
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 17 (8) , 6688-6693
PAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinoma: Am J Transl Res. 2016; 8(8): 3387-3397
[This corrects the article on p. 3387 in vol. 8, PMID: 27648129.].
- 1 January 2025
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 17 (8) , 6688-6693
PAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinoma: Am J Transl Res. 2016; 8(8): 3387-3397
[This corrects the article on p. 3387 in vol. 8, PMID: 27648129.].
- Open Access
- 6 May 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 615
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma
The loss of major histocompatibility complex class I (MHC I) molecules is an important mechanism by which cancer cells escape immunosurveillance in head and neck squamous cell carcinoma (HNSCC). Several long non-coding RNAs (lncRNAs) have been implicated in immune response and regulation including antigen processing and presentation. However, few studies on lncRNAs regulating MHC I expression in HNSCC have been conducted. In this study, MHC I related lncRNAs were identified from the The Cancer Genome Atlas (TCGA) HNSCC database. One of the lncRNAs, long intergenic non-protein coding RNA 2195 (LINC02195), was found to be associated with genes encoding MHC I molecules and patient prognosis in the TCGA database. KEGG and GO analyses suggested that LINC02195 was closely related to antigen processing and presentation. qRT-PCR revealed high expression of LINC02195 in human HNSCC tissues and HNSCC cell lines compared with normal mucosal tissues. in situ hybridization of the HNSCC tissue microarray revealed a correlation between high LINC02195 expression and a favorable prognosis in our patient cohort. Silencing of LINC02195 decreased MHC I protein expression, as evidenced by western blotting. Multiplex immunochemistry was performed to reveal the positive correlation between high LINC02195 expression and an increased number of CD8+ and CD4+ T cells in the tumor microenvironment. Based on our study, LINC02195 is a promising prognostic marker and a target for future therapeutic interventions.
- 6 May 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 615
Open AccessLong Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma
The loss of major histocompatibility complex class I (MHC I) molecules is an important mechanism by which cancer cells escape immunosurveillance in head and neck squamous cell carcinoma (HNSCC). Several long non-coding RNAs (lncRNAs) have been implicated in immune response and regulation including antigen processing and presentation. However, few studies on lncRNAs regulating MHC I expression in HNSCC have been conducted. In this study, MHC I related lncRNAs were identified from the The Cancer Genome Atlas (TCGA) HNSCC database. One of the lncRNAs, long intergenic non-protein coding RNA 2195 (LINC02195), was found to be associated with genes encoding MHC I molecules and patient prognosis in the TCGA database. KEGG and GO analyses suggested that LINC02195 was closely related to antigen processing and presentation. qRT-PCR revealed high expression of LINC02195 in human HNSCC tissues and HNSCC cell lines compared with normal mucosal tissues. in situ hybridization of the HNSCC tissue microarray revealed a correlation between high LINC02195 expression and a favorable prognosis in our patient cohort. Silencing of LINC02195 decreased MHC I protein expression, as evidenced by western blotting. Multiplex immunochemistry was performed to reveal the positive correlation between high LINC02195 expression and an increased number of CD8+ and CD4+ T cells in the tumor microenvironment. Based on our study, LINC02195 is a promising prognostic marker and a target for future therapeutic interventions.
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 17 (6) , 799-806
Overexpression of Malic Enzyme 2 Indicates Pathological and Clinical Significance in Oral Squamous Cell Carcinoma
Our study investigated the expression of malic enzyme 2 (ME2) in human oral squamous cell carcinoma (OSCC) and associated pathological and clinical pattern. We demonstrated that human OSCC tissues expressed a high level of ME2, and the overexpression of ME2 is closely connected to a high pathological grade, lymphatic metastasis, large tumor size and human papillomavirus (HPV) (P < 0.001). Similarly, high levels of ME2 expression in OSCC tissue were shown to be correlated with poor prognosis (P < 0.05). The expression of ME2 was correlated with Slug, SOX2, and aldehyde dehydrogenase-1 (ALDH1) immunoreactivity.ME2 was shown to be overexpressed in OSCC tissue and indicated a poor prognosis for OSCC. ME2 may be correlated with several immune markers.
- 1 January 2020
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 17 (6) , 799-806
Open AccessOverexpression of Malic Enzyme 2 Indicates Pathological and Clinical Significance in Oral Squamous Cell Carcinoma
Our study investigated the expression of malic enzyme 2 (ME2) in human oral squamous cell carcinoma (OSCC) and associated pathological and clinical pattern. We demonstrated that human OSCC tissues expressed a high level of ME2, and the overexpression of ME2 is closely connected to a high pathological grade, lymphatic metastasis, large tumor size and human papillomavirus (HPV) (P < 0.001). Similarly, high levels of ME2 expression in OSCC tissue were shown to be correlated with poor prognosis (P < 0.05). The expression of ME2 was correlated with Slug, SOX2, and aldehyde dehydrogenase-1 (ALDH1) immunoreactivity.ME2 was shown to be overexpressed in OSCC tissue and indicated a poor prognosis for OSCC. ME2 may be correlated with several immune markers.